雙能量CT對腎上腺轉(zhuǎn)移瘤及原發(fā)腺瘤鑒別診斷的應(yīng)用研究
[Abstract]:Background and objective in the routine diagnosis of adrenal lesions in radiology, the differential diagnosis of adrenal adenomas and metastatic tumors is the most common one. Definite diagnosis will have an important impact on the staging, treatment and prognosis of adrenal tumors. In the past, CT was single parameter imaging and could not provide more information of pathological changes. Dual-energy CT is a new imaging mode in recent years. It can provide information about the components of lesions through special energy spectrum imaging technology. It has the functions of quantitative analysis of basic substances and energy spectrum analysis. It has been applied to differential diagnosis of tumors at present. The purpose of this study was to analyze the general imaging features of adrenal adenomas and metastatic tumors by conventional CT plain scan and dual-energy enhanced dual-phase scanning, and to analyze the characteristics of energy spectrum parameters of the two types of adrenal adenomas and metastatic tumors. To determine the value of energy spectrum imaging in differentiating adrenal adenoma from metastatic tumor. Materials and methods 35 patients (M 16, F 19, mean age 52.2 鹵12.7 years) with 40 lesions (24 adenomas and 16 metastatic tumors) were analyzed. According to CT value 10HU, 24 adenoma lesions were divided into fat-rich adenomas group (14 lesions, CT value = 10 Hu) and anadiomatous adenomas group (10 lesions, CT value 10HU), and analyzed statistically with metastatic tumors. To determine the significance of each parameter in differential diagnosis between fat-rich adenoma and metastatic tumor and anasteinoma from metastatic tumor. The features of the lesions were as follows: (1) the age of the patient, the size of the tumor (maximum diameter line), the CT value of the plain scan of the tumor, the enhanced CT value, the boundary between the tumor and the adjacent tissue, whether there were calcification, cystic change, necrosis, etc. 2 iodine base value, water base value and fat-iodine base value were analyzed statistically. The threshold values of each parameter were calculated according to the receiver operating characteristic curve (receive operating characteristic curve, ROC) to determine the sensitivity, specificity and Joden index. Results there were 40 lesions in 35 patients, including 24 adenomas (14 fat-rich adenomas, 10 fat-deficient adenomas) and 16 metastatic tumors. There was no statistical difference in the average size, age of onset and sex ratio between fat-rich adenoma, asthenoma and metastatic tumor. The CT value of adrenal sebaceous adenoma group was slightly lower than that of metastatic tumor, and the CT value of anadipose adenoma was slightly higher than that of metastatic tumor, and the difference was not statistically significant. The water base value and fat-iodine base value of fat-rich adenoma and asthenoma were lower than those of metastatic tumor by energy spectrum dual-phase enhanced scanning, and the difference was statistically significant. The biphasic energy spectrum parameters were analyzed by ROC curve, the differentiation of arterial phase was the most significant, and the sensitivity and specificity were higher. The sensitivity of water-based value was higher than that of fat-iodine value, but the specificity of fat-iodine value was higher than that of arterial phase. Conclusion dual-energy CT energy spectrum imaging can improve the sensitivity and specificity of differential diagnosis between adrenal fat-rich adenoma and metastatic adenoma, anadiomatous adenoma and metastatic tumor in contrast-enhanced scanning. Among them, WCad and FCad are of great help in differential diagnosis. They can distinguish adrenal adenoma from metastatic adenoma which is difficult to distinguish by conventional CT plain scan and multi-phase enhancement, and can significantly improve the sensitivity and specificity of differential diagnosis between adipocytic adenoma and metastatic tumor. Provide help to guide clinical work.
【學(xué)位授予單位】:鄭州大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2013
【分類號】:R736.6;R730.44
【參考文獻】
相關(guān)期刊論文 前8條
1 余幫龍;蔣世民;張福洲;何孔明;;32例腎上腺轉(zhuǎn)移瘤的CT鑒別診斷探討[J];重慶醫(yī)學(xué);2010年12期
2 劉永強;方春;;CT值在腎上腺腺瘤診斷中的應(yīng)用價值及其閾值選擇[J];放射學(xué)實踐;2009年10期
3 劉婧;王鶴;王霄英;邱建星;容蓉;郭小超;張玉東;胡娟;董健;李瑋;蔣學(xué)祥;;雙能CT成像鑒別腎上腺良惡性病變的初步研究[J];放射學(xué)實踐;2012年03期
4 Y.H. Lee;K.K. Park;H.T. Song;S. Kim;J.S. Suh;唐光健;;使用與不使用金屬偽影減低軟件的雙能量CT紅寶石能譜成像中金屬偽影減低的對照性研究[J];國際醫(yī)學(xué)放射學(xué)雜志;2012年04期
5 李軍,孔垂?jié)?腎上腺轉(zhuǎn)移癌的診斷和治療(附6例報告)[J];臨床泌尿外科雜志;2002年06期
6 祝捷,唐孝達,朱江;腎上腺偶發(fā)瘤的臨床探討(附50例報告)[J];臨床泌尿外科雜志;2002年12期
7 姜新,郭啟勇,吳恩福,陳偉建,王思齊;MSCT三期掃描對腎上腺腺瘤和轉(zhuǎn)移瘤鑒別診斷的研究[J];中國臨床醫(yī)學(xué)影像雜志;2004年04期
8 張晶;李為民;魏秀芳;朱敏;;腎上腺腫瘤CT表現(xiàn)及其病理組織學(xué)基礎(chǔ)[J];牡丹江醫(yī)學(xué)院學(xué)報;2007年03期
,本文編號:2462512
本文鏈接:http://sikaile.net/yixuelunwen/yundongyixue/2462512.html